UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
H&R Block
HRB
$5.84B
| $1.01M | ﹤0.01% |
43,127
-47,044
| -52% | -$1.13M |
|
4202
Fate Therapeutics
FATE
$316M
| $1.01M | ﹤0.01% |
51,722
-119,783
| -70% | -$1.9M |
|
|
TTP
4203
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
| $1.01M | ﹤0.01% |
19,634
+2,734
| +16% | +$135K |
|
4204
ATN International
ATNI
$486M
| $1.01M | ﹤0.01% |
18,192
+6,164
| +51% | +$351K |
|
|
CTR
4205
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
| $1.01M | ﹤0.01% |
23,474
+1,147
| +5% | +$47.6K |
|
4206
StoneX
SNEX
$8B
| $1.01M | ﹤0.01% |
104,363
+41,983
| +67% | +$347K |
|
4207
iShares MSCI Philippines ETF
EPHE
$147M
| $1.01M | ﹤0.01% |
29,302
+1,309
| +5% | +$45.1K |
|
4208
First Trust Energy AlphaDEX Fund
FXN
$390M
| $1.01M | ﹤0.01% |
95,202
-19,158
| -17% | -$185K |
|
4209
Haverty Furniture Companies
HVT
$449M
| $1M | ﹤0.01% |
49,894
+29,808
| +148% | +$602K |
|
4210
Univest Financial
UVSP
$1.18B
| $1M | ﹤0.01% |
37,488
+11,710
| +45% | +$303K |
|
|
MPV
4211
Barings Participation Investors
MPV
$175M
| $1M | ﹤0.01% |
62,200
-10,933
| -15% | -$180K |
|
|
CBPO
4212
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1M | ﹤0.01% |
8,617
+3,828
| +80% | +$443K |
|
4213
VanEck Brazil Small-Cap ETF
BRF
$20.5M
| $1M | ﹤0.01% |
36,475
-3,402
| -9% | -$83.3K |
|
4214
CALL
Johnson Controls International
JCI
$93.2B
| $1M | ﹤0.01% |
24,600
-1,000
| -4% | -$42.2K |
|
|
EOD
4215
Allspring Global Dividend Opportunity Fund
EOD
$286M
| $1M | ﹤0.01% |
176,670
+24,234
| +16% | +$133K |
|
4216
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$414M
| $997K | ﹤0.01% |
26,445
-4,682
| -15% | -$172K |
|
4217
PUT
The GEO Group
GEO
$4.23B
| $997K | ﹤0.01% |
+60,000
| New | +$911K |
|
4218
Helios Technologies
HLIO
$2.73B
| $997K | ﹤0.01% |
21,572
+20,471
| +1,859% | +$878K |
|
4219
Acuity Brands
AYI
$10.7B
| $996K | ﹤0.01% |
7,213
-835
| -10% | -$107K |
|
4220
SiriusPoint
SPNT
$2.64B
| $994K | ﹤0.01% |
94,465
+37,379
| +65% | +$363K |
|
4221
NRC Health Common Stock
NRC
$467M
| $992K | ﹤0.01% |
15,037
+5,833
| +63% | +$357K |
|
4222
Flowers Foods
FLO
$1.53B
| $990K | ﹤0.01% |
45,547
-3,125
| -6% | -$67.9K |
|
4223
Sinclair Inc
SBGI
$968M
| $990K | ﹤0.01% |
29,698
-19,838
| -40% | -$739K |
|
4224
Kelly Services Class A
KELYA
$534M
| $987K | ﹤0.01% |
43,689
+18,095
| +71% | +$408K |
|
4225
PUT
Iron Mountain
IRM
$36.6B
| $985K | ﹤0.01% |
30,900
+20,800
| +206% | +$682K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.